DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

72 hedge funds and large institutions have $391M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+22
Holders Change %
+44%
% of All Funds
1.65%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
27
Increased
16
Reduced
16
Closed
5
Calls
$20K
Puts
$1.19M
Net Calls
-$1.17M
Net Calls Change
-$3.45M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
$11.8M
2
Goldman Sachs
Goldman Sachs
New York
$7.54M
3
GTC
Ghost Tree Capital
New York
$9.08M
4
AG
Artal Group
Luxembourg
$4.06M
5
Millennium Management
Millennium Management
New York
$3.9M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
$37.6M
2
6CM
683 Capital Management
New York
$1.2M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
$1.45M
4
Renaissance Technologies
Renaissance Technologies
New York
$2.77M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
$16.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
DCM
76
Delpha Capital Management
New York
– -$4K -467 Closed
LTFS
77
Ladenburg Thalmann Financial Services
Florida
– -$1K -100 Closed
MIM
78
Monashee Investment Management
Massachusetts
– -$1.88M – –
1 2 3
4